Efficacy and Tolerability of LAS41004 Formulations in a Non-occlusive Psoriasis Plaque Test

NCT01462643 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: LAS41004

Sponsor

Almirall, S.A.

Collaborators

[object Object]